HHLR Advisors’s Aligos Therapeutics ALGS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $550K | Hold |
|
|||||
|
2025
Q1 | $629K | Hold |
|
|||||
|
2024
Q4 | $3.04M | Hold |
|
|||||
|
2024
Q3 | $660K | Sell |
|
|||||
|
2024
Q2 | $1.09M | Buy |
|
|||||
|
2024
Q1 | $1.87M | Hold |
|
|||||
|
2023
Q4 | $1.27M | Sell |
|
|||||
|
2023
Q3 | $1.73M | Hold |
|
|||||
|
2023
Q2 | $2.24M | Hold |
|
|||||
|
2023
Q1 | $2.02M | Hold |
|
|||||
|
2022
Q4 | $2.2M | Sell |
|
|||||
|
2022
Q3 | $2.6M | Hold |
|
|||||
|
2022
Q2 | $2.86M | Hold |
|
|||||
|
2022
Q1 | $5.08M | Hold |
|
|||||
|
2021
Q4 | $28.1M | Hold |
|
|||||
|
2021
Q3 | $36.7M | Buy |
|
|||||
|
2021
Q2 | $44.1M | Hold |
|
|||||
|
2021
Q1 | $49.2M | Hold |
|
|||||
|
2020
Q4 | $59.9M | Buy |
|